Summit Therapeutics Chief Accounting Officer Receives 100,000 RSU Grant
Summit Therapeutics Inc.
Subscribe to track SMMT
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📋 Form 4 Filed for Summit Therapeutics Inc. ($SMMT) Insider: Anand Bhaskar (Chief Accounting Officer) Transaction: Award / Grant of 100,000 Restricted Stock Units (RSUs) at $0.00 Total Value: $0.00 Shares Owned Following Transaction: 261,047 (Direct) Significance: Low (Equity compensation grant)
Comprehensive Analysis
Insider Transaction Overview
On October 14, 2026, a Form 4 was filed by Anand Bhaskar, the Chief Accounting Officer of Summit Therapeutics Inc. ($SMMT), reporting an equity compensation grant.
Key Transaction Highlights
- Date of Transaction: October 8, 2026
- Security: Common Stock (Restricted Stock Units)
- Transaction Code:
A(Grant/Award under an equity incentive plan) - Shares Acquired: 100,000 shares
- Price per Share: $0.00
- Post-Transaction Beneficial Ownership: 261,047 shares (includes shares acquired via the employee stock purchase plan)
- Ownership Type: Direct
Vesting Terms & Notes
According to footnote disclosure, the 100,000 restricted stock units were granted under the Issuer's Amended and Restated 2020 Stock Incentive Plan. The units are scheduled to cliff-vest on October 8, 2029, conditional upon continued employment.
Significance
This transaction represents a routine equity compensation award rather than an open-market purchase or sale. As such, it carries Low informational significance for market trading signals.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.